CD4 and myeloid sarcoma: While much focus is typically paid to CD4+ T cells in MS pathology, as there is a strong association of MS susceptibility with MHC class II alleles, current evidence suggests there may be antigen-driven activation of CD8+ T cells and that they may play a significant role in MS disease progression [182].